We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current E1LV34 market cap is 113.66B. The company's latest EPS is USD 25.7844 and P/E is 18.72.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 42.65B | 42.58B | 43.89B | 45.11B | 45.44B |
| Operating Income | 1.26B | 3.2B | 3.27B | 1.67B | 946M |
| Net Income | 856M | 2.25B | 2.3B | 1.02B | 418M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 121.87B | 138.64B | 156.6B | 171.34B | 177.01B |
| Operating Income | 7.06B | 8.74B | 8.62B | 8.75B | 9.09B |
| Net Income | 4.57B | 6.1B | 6.03B | 5.99B | 5.98B |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 108.93B | 111.89B | 112.99B | 116.53B | 116.89B |
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 0 | 0 | 0 | 0 | 0 |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 86.62B | 97.46B | 102.77B | 108.93B | 116.89B |
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 0 | 0 | 0 | 0 | 0 |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | N/A | N/A | N/A | N/A | N/A |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | N/A | N/A | N/A | N/A | N/A |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 113.66B |
| Price to Earnings Ratio | 18.72 |
| Price to Sales Ratio | 0.63 |
| Price to Cash Ratio | 13.5 |
| Price to Book Ratio | 0.96 |
| Dividend Yield | 1.12% |
| Shares Outstanding | 231.92M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -12.04% |
| 52 Week High | 638.82 |
| 52 Week Low | 437.40 |
| Spread (Intraday) | 3.43 (0.71%) |
| Company Name | Elevance Health Inc |
| Address |
220 virginia avenue indianapolis, indiana 46204 |
| Website | https://ww.elevancehealth.com |
| Industry | hospital & medical svc plans (6324) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
